These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29284156)

  • 1. Vancomycin dosing in chronic high-flux haemodialysis: a systematic review.
    Hui K; Upjohn L; Nalder M; Buising K; Pedagogos E; Nelson C; Kirkpatrick CMJ; Kong DCM
    Int J Antimicrob Agents; 2018 May; 51(5):678-686. PubMed ID: 29284156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ; Mueller BA
    J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.
    Tkachuk S; Collins K; Ensom MHH
    Paediatr Drugs; 2018 Apr; 20(2):153-164. PubMed ID: 29344778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
    Brown DL; Lalla CD; Masselink AJ
    Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
    Fu CF; Huang JD; Wang JT; Lin SW; Wu CC
    PLoS One; 2018; 13(3):e0193585. PubMed ID: 29505620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H; Dallas L; Nair S; Palmer J; Thaikandy S; Hutchison C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32408589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
    Hui K; Patel K; Nalder M; Nelson C; Buising K; Pedagogos E; Kong DCM; Kirkpatrick CMJ
    J Antimicrob Chemother; 2019 Jan; 74(1):130-134. PubMed ID: 30215721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
    Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
    BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?
    Patel K; Crumby AS; Maples HD
    Paediatr Drugs; 2015 Apr; 17(2):97-103. PubMed ID: 25644329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.
    Janssen EJ; Välitalo PA; Allegaert K; de Cock RF; Simons SH; Sherwin CM; Mouton JW; van den Anker JN; Knibbe CA
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1013-21. PubMed ID: 26643337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin dosing in children: what is the question?
    Cole TS; Riordan A
    Arch Dis Child; 2013 Dec; 98(12):994-7. PubMed ID: 23956256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis.
    Cardone KE; Chen WZ; Grabe DW; Batzold A; Manley HJ; Lodise TP
    J Antimicrob Chemother; 2014 Jul; 69(7):1873-6. PubMed ID: 24722842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
    Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
    J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis.
    Lanke S; Yu T; Rower JE; Balch AH; Korgenski EK; Sherwin CM
    J Clin Pharmacol; 2017 Jan; 57(1):77-84. PubMed ID: 27291466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.